Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center

被引:0
作者
Botella, Carmen [1 ]
Galian, Jose Antonio [1 ]
Jimenez-Coll, Victor [1 ]
Fernandez-Gonzalez, Marina [1 ]
Morales, Francisco [2 ]
Martinez-Gomez, Gloria [3 ]
Gonzalez-Lopez, Rosana [1 ]
Alegria, Maria Jose [1 ]
Moya, Maria Rosa [1 ]
Martinez-Banaclocha, Helios [1 ]
Minguela, Alfredo [1 ]
Legaz, Isabel [4 ]
Llorente, Santiago [2 ]
Muro, Manuel [1 ]
机构
[1] Univ Clin Hosp Virgen Arrixaca, Biomed Res Inst Murcia IMIB, Immunol Serv, Murcia 30120, Spain
[2] Univ Clin Hosp Virgen Arrixaca, Biomed Res Inst Murcia IMIB, Nephrol Serv, Murcia 30120, Spain
[3] Univ Clin Hosp Virgen Arrixaca, Biomed Res Inst Murcia IMIB, Urol Serv, Murcia 30120, Spain
[4] Univ Murcia, Biomed Res Inst Murcia IMIB, Fac Med, Dept Legal & Forens Med,Reg Campus Int Excellence, Murcia 30100, Spain
来源
LIFE-BASEL | 2024年 / 14卷 / 11期
关键词
donor-derived circulating free DNA (dd-cfDNA); kidney transplant; graft rejection; biomarker; non-rejection (NR); antibody-mediated rejection (ABMR); borderline rejection (BR); T-cell-mediated rejection (TCMR); TRANSPLANTATION; REJECTION;
D O I
10.3390/life14111491
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
(1) Background: donor-derived circulating free DNA (dd-cfDNA), an innovative biomarker with great potential for the early identification and prevention of graft damage. (2) Methods: Samples were collected prospectively and the study was performed retrospectively to analyze dd-cfDNA plasma levels in 30 kidney transplant patients during their post-transplant follow-up (15 days, 3, 6, and 9 months), to determine if the result could be of interest in the identification of possible adverse events, especially rejection. The aim was to verify whether the data on sensitivity, specificity, NPV, and PPV compare with reference values and creatinine values. (3) Results: We observed levels of dd cfDNA > 1% in six of nine patients with active rejection (ABMR or TCMR) and elevated values (>0.5%) in two other patients in this rejection group. Our results show low values of sensitivity = 50%, specificity = 61.11%, rejection NPV = 64.71%, and rejection PPV = 46.13% of the technique compared to reference values previously published. With respect to creatinine, only for TCRM, we observed better results for dd-cfDNA in these parameters than in creatinine. Also, our data suggest that dd-cfDNA could help to differentiate those patients with dnDSAs that are going to through rejection better than creatinine, specially at 15 d post transplant. In this study, this appears to have no positive predictive value for borderline rejection (BR) or TCMR IA. (4) Conclusions: plasma levels of dd-cfDNA could be considered an additional or alternative biomarker for graft rejection monitoring in early post-kidney transplant up to several months before its clinical presentation, especially for patients with suspected TCMR or ABMR.
引用
收藏
页数:12
相关论文
共 50 条
[31]   Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial [J].
Akifova, Aylin ;
Budde, Klemens ;
Amann, Kerstin ;
Buettner-Herold, Maike ;
Choi, Mira ;
Oellerich, Michael ;
Beck, Julia ;
Bornemann-Kolatzki, Kirsten ;
Schuetz, Ekkehard ;
Bachmann, Friederike ;
Halleck, Fabian ;
von Hoerschelmann, Ellen ;
Koch, Nadine ;
Schrezenmeier, Eva ;
Seelow, Evelyn ;
Waiser, Johannes ;
Zukunft, Bianca ;
Eckardt, Kai-Uwe ;
Halbritter, Jan ;
Kettritz, Ralph ;
Del Moral, Covadonga Lopez ;
Lachmann, Nils ;
Stauch, Diana ;
Niemann, Matthias ;
Schmidt, Danilo ;
Halloran, Philip F. ;
Osmanodja, Bilgin .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
[32]   The detection of donor-derived cell-free DNA may serve as a biomarker for the early detection of chronic lung allograft dysfunction [J].
Bansal, Sandhya ;
Fleming, Timothy ;
Mohanakumar, Thalachallour .
EBIOMEDICINE, 2019, 40 :13-14
[33]   Donor-derived cell-free DNA as a diagnostic marker for kidney-allograft rejection: A systematic review and meta-analysis [J].
Xing, Yanbo ;
Guo, Qiang ;
Wang, Cong ;
Shi, Haoying ;
Zheng, Jiarui ;
Jia, Yijun ;
Li, Chengyong ;
Hao, Chuan .
BIOMOLECULES AND BIOMEDICINE, 2024, 24 (04) :731-740
[34]   Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy [J].
Verhoeven, Jeroen G. H. P. ;
Hesselink, Dennis A. ;
Peeters, Annemiek M. A. ;
de Jonge, Evert ;
von der Thusen, Jan H. ;
van Schaik, Ron H. N. ;
Matic, Maja ;
Baan, Carla C. ;
Manintveld, O. C. ;
Boer, Karin .
TRANSPLANT INTERNATIONAL, 2022, 35 (01)
[35]   Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care [J].
Keller, Michael ;
Sun, Junfeng ;
Mutebi, Cedric ;
Shah, Pali ;
Levine, Deborah ;
Aryal, Shambhu ;
Iacono, Aldo ;
Timofte, Irina ;
Mathew, Joby ;
Varghese, Anu ;
Giner, Cassandra ;
Agbor-Enoh, Sean .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04) :458-466
[36]   Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study [J].
Nie, Weijian ;
Su, Xiaojun ;
Liu, Longshan ;
Li, Jun ;
Fu, Qian ;
Li, Xirui ;
Wu, Chenglin ;
Wang, Jiali ;
Deng, Ronghai ;
Chen, E. ;
Yang, Shicong ;
Li, Shujuan ;
Zhang, Huanxi ;
Wang, Changxi .
FRONTIERS IN MEDICINE, 2022, 8
[37]   Noninvasive graft monitoring using donor-derived cell-free DNA in Japanese liver transplantation [J].
Kanamori, Hiroki ;
Yamada, Yohei ;
Ito, Yoko ;
Shirosaki, Koji ;
Yamagishi, Satoko ;
Maeda, Yutaro ;
Kudo, Yumi ;
Umeyama, Tomoshige ;
Takahashi, Nobuhiro ;
Kato, Mototoshi ;
Hasegawa, Yasushi ;
Matsubara, Kentaro ;
Shinoda, Masahiro ;
Obara, Hideaki ;
Irie, Rie ;
Tsujikawa, Hanako ;
Okita, Hajime ;
Nguyen, Phuong Thanh ;
Saigo, Kenichi ;
Mitsunaga, Shigeki ;
Inoue, Ituro ;
Kitagawa, Yuko ;
Kuroda, Tatsuo .
HEPATOLOGY RESEARCH, 2024, 54 (03) :300-314
[38]   The impact of active cytomegalovirus infection on donor-derived cell-free DNA testing in heart transplant recipients [J].
Alam, Amit H. ;
Van Zyl, Johanna ;
Shakoor, Hira I. ;
Farsakh, Dana ;
Abdelrehim, Ahmad B. ;
Maliakkal, Neville ;
Jamil, Aayla K. ;
Patel, Raksha ;
Felius, Joost ;
McKean, Staci ;
Hall, Shelley A. .
CLINICAL TRANSPLANTATION, 2024, 38 (03)
[39]   Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients [J].
Kueng, Nicholas ;
Arcioni, Severine ;
Sandberg, Fanny ;
Kuhn, Christian ;
Banz, Vanessa ;
Largiader, Carlo R. ;
Sidler, Daniel ;
Amstutz, Ursula .
FRONTIERS IN GENETICS, 2023, 14
[40]   Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients [J].
Keller, Michael B. ;
Meda, Rohan ;
Fu, Sheng ;
Yu, Kai ;
Jang, Moon Kyoo ;
Charya, Ananth ;
Berry, Gerald J. ;
Marboe, Charles C. ;
Kong, Hyesik ;
Luikart, Helen ;
Ponor, Ileana L. ;
Shah, Pali D. ;
Khush, Kiran K. ;
Nathan, Steven D. ;
Agbor-Enoh, Sean .
AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (10) :2451-2457